Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T.

J Matern Fetal Neonatal Med. 2012 May;25(5):498-507. doi: 10.3109/14767058.2011.591461. Epub 2011 Aug 25.

2.

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, Dong Z, Tarca A, Gaurav B, Hassan SS.

J Matern Fetal Neonatal Med. 2011 Oct;24(10):1187-207. doi: 10.3109/14767058.2011.589932. Epub 2011 Aug 9.

3.

Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, Chaemsaithong P, Dong Z, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2014 Jan;27(2):132-44. doi: 10.3109/14767058.2013.806905. Epub 2013 Aug 8.

4.

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS.

J Matern Fetal Neonatal Med. 2008 May;21(5):279-87. doi: 10.1080/14767050802034545.

5.

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.

Am J Obstet Gynecol. 2013 Apr;208(4):287.e1-287.e15. doi: 10.1016/j.ajog.2013.01.016. Epub 2013 Jan 17.

6.

Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.

Chaiworapongsa T, Romero R, Gotsch F, Kusanovic JP, Mittal P, Kim SK, Erez O, Vaisbuch E, Mazaki-Tovi S, Kim CJ, Dong Z, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Feb;23(2):167-78.

7.

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.

Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA.

J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23. doi: 10.1080/14767050701830480.

8.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

9.

Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.

Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS.

J Perinat Med. 2011 Nov;39(6):641-52. doi: 10.1515/JPM.2011.098. Epub 2011 Aug 17.

10.

Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.

Oggè G, Romero R, Kusanovic JP, Chaiworapongsa T, Dong Z, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gonzalez JM, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Aug;23(8):820-7. doi: 10.3109/14767050903366119.

11.

An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.

Romero R, Chaiworapongsa T, Erez O, Tarca AL, Gervasi MT, Kusanovic JP, Mittal P, Ogge G, Vaisbuch E, Mazaki-Tovi S, Dong Z, Kim SK, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Dec;23(12):1384-99. doi: 10.3109/14767051003681121. Epub 2010 May 12.

12.

The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.

Aggarwal PK, Chandel N, Jain V, Jha V.

J Hum Hypertens. 2012 Apr;26(4):236-41. doi: 10.1038/jhh.2011.29. Epub 2011 Mar 31.

PMID:
21451568
13.

Circulating angiogenic and antiangiogenic factors in women with eclampsia.

Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, Sorokin Y, Karumanchi SA.

Am J Obstet Gynecol. 2011 Feb;204(2):152.e1-9. doi: 10.1016/j.ajog.2010.08.049. Epub 2010 Nov 9.

14.

Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country.

Reyes LM, García RG, Ruiz SL, Broadhurst D, Aroca G, Davidge ST, López-Jaramillo P.

Growth Factors. 2012 Jun;30(3):158-66. doi: 10.3109/08977194.2012.674035. Epub 2012 Apr 10.

PMID:
22486210
15.

Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.

Stampalija T, Chaiworapongsa T, Romero R, Chaemsaithong P, Korzeniewski SJ, Schwartz AG, Ferrazzi EM, Dong Z, Hassan SS.

J Matern Fetal Neonatal Med. 2013 Sep;26(14):1359-70. doi: 10.3109/14767058.2013.784256. Epub 2013 May 20.

PMID:
23488689
16.

Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.

Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y.

J Clin Endocrinol Metab. 2007 Jul;92(7):2672-9. Epub 2007 Apr 10.

PMID:
17426083
17.

Differential expression of Vegfr-2 and its soluble form in preeclampsia.

Munaut C, Lorquet S, Pequeux C, Coulon C, Le Goarant J, Chantraine F, Noël A, Goffin F, Tsatsaris V, Subtil D, Foidart JM.

PLoS One. 2012;7(3):e33475. doi: 10.1371/journal.pone.0033475. Epub 2012 Mar 12.

18.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.

PMID:
23806447
19.

Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.

Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, Espinoza J, Gonçalves LF, Edwin S, Mazor M.

J Matern Fetal Neonatal Med. 2005 Jul;18(1):9-16.

PMID:
16105786
20.

Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.

Yinon Y, Ben Meir E, Berezowsky A, Weisz B, Schiff E, Mazaki-Tovi S, Lipitz S.

Am J Obstet Gynecol. 2014 Feb;210(2):141.e1-7. doi: 10.1016/j.ajog.2013.09.022. Epub 2013 Sep 18.

PMID:
24055584
Items per page

Supplemental Content

Write to the Help Desk